Dental manufacturing: catalogue consumables beside patient-specific parts

Two production logics that do not share a schedule

Catalogue manufacturing wants long runs, stable formulations and inventory positioned near distributors. Restorative work wants a queue discipline measured in days, because a patient is waiting with a temporary in place. The economics differ too: a consumable earns through gross margin on volume, while a restoration earns through skilled labour applied once. Businesses that combine them typically keep the laboratory operation physically and managerially separate, sharing only regulatory infrastructure and brand. The failure mode is running the laboratory on factory planning logic, which produces a backlog nobody can expedite because everything is urgent.

The digital chain moved work, it did not remove it

Intraoral scanning, design software and chairside milling shifted where value is created. Some restorations are now produced in the practice, bypassing the laboratory entirely; others are designed centrally and milled in production centres serving many clinics. Laboratories that adapted became design and finishing operations rather than casting shops, and the technicians who thrived were those who could work in software. For manufacturers, the consequence is that the buyer of equipment changed: selling a mill to a practice is a different sale, with different support expectations, from selling one to a laboratory.

Materials are qualified per indication, not per material

A ceramic suitable for a single crown may be unsuitable for a long-span bridge, and the manufacturer's instructions define which indications a material supports. Those limits carry real weight because a clinician working outside them is exposed if the restoration fails, and the manufacturer will point to the instructions. Introducing a material therefore involves generating indication-specific evidence, not simply demonstrating strength. It also means the sales conversation is technical and clinician-to-clinician, which is why dental manufacturers invest so heavily in education programmes that look like marketing but function as qualification of the user.

Distributors hold the relationship, clinicians make the choice

Most consumables reach practices through dealers who carry thousands of items, run field representatives and provide equipment service. The dealer controls shelf presence, but the practitioner specifies the brand, often out of familiarity and handling preference rather than measurable performance. This produces a market where switching is slow and where trials and hands-on courses matter more than price lists. Corporate practice groups are changing this by centralising purchasing and negotiating on cost, which pressures brand loyalty and pushes manufacturers to argue on chair time and predictability instead of preference. Direct online selling has eroded some of that structure, though the service and equipment side keeps dealers relevant in a way pure consumables do not.

High mix, small batches, and the cost of doing it twice

Both halves of dental production carry heavy variety: shades, sizes, indications, and in restorative work a unique geometry every time. Rework is the silent cost. A remake in a laboratory consumes material, machine time, technician hours and courier cost, and it damages the clinical relationship because a patient has to return. Reducing remakes is mostly about the front end: scan quality, prescription completeness and a design review before milling. Manufacturers who measure remake causes rather than remake rates find that most originate outside their own building, which changes what they should be fixing.

Frequently asked questions

Is a milled crown a manufactured product or a custom-made device?

It is generally handled as a custom-made device, produced to a named clinician's prescription for an individual patient, which sits on a different regulatory pathway from series-produced products. The manufacturer still needs a quality system, traceability of the materials used and a declaration accompanying the item, but the route to market differs from a catalogue product. The blanks and resins themselves are separately regulated products supplied to the laboratory with defined indications.

Why do dental brands invest so much in clinician education?

Because the practitioner chooses the product and because technique determines whether it performs. A material used outside its indication or handled incorrectly fails clinically, and the failure attaches to the brand regardless of cause. Education programmes qualify the user, build familiarity that resists switching, and generate the clinical advocates who influence peers. They also generate feedback on handling problems that would otherwise appear only as unexplained complaints.

What is changing as practices consolidate into groups?

Purchasing moves from the individual clinician to a central function that negotiates on total cost and standardises across sites. That erodes the brand preference that historically protected margins, and it introduces tender-style buying to a market that operated on relationships. Manufacturers respond by arguing on outcomes the group can measure, such as chair time, remake rates and predictability across many operators, rather than on handling characteristics that appeal to an individual practitioner.